DE3585312D1 - Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden. - Google Patents

Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.

Info

Publication number
DE3585312D1
DE3585312D1 DE8585308186T DE3585312T DE3585312D1 DE 3585312 D1 DE3585312 D1 DE 3585312D1 DE 8585308186 T DE8585308186 T DE 8585308186T DE 3585312 T DE3585312 T DE 3585312T DE 3585312 D1 DE3585312 D1 DE 3585312D1
Authority
DE
Germany
Prior art keywords
hexahydro
carboxamide
oxo
dimethyl
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585308186T
Other languages
English (en)
Inventor
Zoltan Meszaros
Jozsef Knoll
Istvan Hermecz
Peter Szentmikloisi
Agnes Horvath
Lelle Vasvari
Gabor Kovacs
Klara Gyires
Sandor Virag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Application granted granted Critical
Publication of DE3585312D1 publication Critical patent/DE3585312D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8585308186T 1984-11-12 1985-11-11 Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden. Expired - Fee Related DE3585312D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU419284 1984-11-12

Publications (1)

Publication Number Publication Date
DE3585312D1 true DE3585312D1 (de) 1992-03-12

Family

ID=10967278

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585308186T Expired - Fee Related DE3585312D1 (de) 1984-11-12 1985-11-11 Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.

Country Status (5)

Country Link
US (1) US4666912A (de)
EP (1) EP0182569B1 (de)
JP (1) JPS61171420A (de)
AT (1) ATE72115T1 (de)
DE (1) DE3585312D1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201551B (en) * 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same
DE19904392A1 (de) 1999-02-04 2000-08-10 Bayer Ag Polycarbonat-Formmassen mit verbesserten antistatischen Eigenschaften
DE10050662A1 (de) 2000-10-13 2002-04-18 Gruenenthal Gmbh Substituierte 3,4-Dihydro-pyrido[1,2-a]pyrimidine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU174901B (hu) * 1976-06-25 1980-04-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh pirido/1,2-a/pirimidina

Also Published As

Publication number Publication date
EP0182569A2 (de) 1986-05-28
US4666912A (en) 1987-05-19
ATE72115T1 (de) 1992-02-15
EP0182569A3 (en) 1987-10-14
JPS61171420A (ja) 1986-08-02
JPH0351688B2 (de) 1991-08-07
EP0182569B1 (de) 1992-01-29

Similar Documents

Publication Publication Date Title
DE58902094D1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
DE69403969D1 (de) Levobupivacain nützlich zur behandlung von chronischen schmerzen
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE69110779D1 (de) Schilddrüsenhormone zur kardialen behandlung.
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
DE69305267D1 (de) Zusammensetzung zur Behandlung von Mastitis und Metritis
NO830527L (no) Analogifremgangsmaate for fremstilling av 2,3-diaryl-5-halogenthiofener
ATE222491T1 (de) Melatonin-derivate zur verwendung in der behandlung von schlafstörungen
DE69301750D1 (de) Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
ATE239470T1 (de) Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
DE3875016D1 (de) Therapeutikum zur behandlung von aids.
DE68909750D1 (de) Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias.
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
ATE150645T1 (de) Verwendung von bmy 14802 zur behandlung von angstzuständen bei patienten mit benzodiazepin- entzugserscheinungen
ATE79759T1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
DE69830811D1 (de) Verwendung von Oxazolidinonderivaten zur Behandlung von Psoriasis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee